SCHEMBL989382

SCHEMBL989382

[c]1ccc2c3cccc4cccc(c5cccc1c25)c43

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 5/20 0.44
HPGD P15428 4/20 0.44
CYP1A2 P05177 3/20 0.44
THRB P10828 1/20 0.44
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
TSHR P16473 4/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2A6 P11509 1/20 0.33
MAPK1 P28482 2/20 0.32
CASP1 P29466 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150633 0.91 CYP1A2 (0.35) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1046556 0.91 CYP1A2 (0.35) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL2413155 0.87 CYP1A2 (0.38) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL2408476 0.87 CYP1A2 (0.38) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1081612 0.85 ALDH1A1 (0.32) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL2411403 0.85 ALDH1A1 (0.32) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL2407910 0.84 CYP1A2 (0.39) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL2407073 0.83 CYP1A2 (0.38) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1899901 0.82 ALDH1A1 (0.61) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL1683365 0.80 ALDH1A1 (0.46) ALDH1A1HSD17B10HPGDCYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294727-B1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER NOVALED GMBH (DE) 2021-08-04 EP claimed
CN-107750404-B Organic light emitting diode comprising different host compounds in first and second electron transport layers 诺瓦尔德股份有限公司 2021-06-04 CN claimed
EP-3294727-A1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER Novaled GmbH (DE) 2018-03-21 EP claimed
WO-2016180891-A1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER NOVALED GMBH (DE) 2016-11-17 WO claimed
EP-3093288-A1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER Novaled GmbH (DE) 2016-11-16 EP claimed
EP-2273512-B1 Conjugated polymers comprising triarylamine-arylenevinylene units, synthesis and use of the same MERCK PATENT GMBH (DE) 2016-07-20 EP claimed
EP-2161272-A1 Phenanthrolines BASF SE (DE) 2010-03-10 EP claimed
US-20090128010-A1 Green Electroluminescent Compounds and Organic Electroluminescent Device Using the Same HYUN SEUNG-HAK 2009-05-21 US claimed
EP-1922382-A1 GREEN ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Gracel Display Inc. (KR) 2008-05-21 EP claimed
WO-2007021117-A1 GREEN ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2007-02-22 WO claimed
EP-0125701-B1 POLYCYCLIC AROMATIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1988-08-03 EP claimed
US-4719236-A ANTITUMOR BURROUGHS WELLCOME CO. (US) 1988-01-12 US claimed
EP-0125701-A2 Polycyclic aromatic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1984-11-21 EP claimed
CN-114423742-B Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-05-28 CN disclosed
WO-2024070862-A1 PHTHALOCYANINE PIGMENT, PHTHALOCYANINE COMPOUND, COLORING COMPOSITION, METHOD FOR PRODUCING PHTHALOCYANINE PIGMENT, AND METHOD FOR PRODUCING COLORING COMPOSITION 富士フイルム株式会社 2024-04-04 WO disclosed
CN-111527094-B Compound, polymer compound, material for organic element, organic electroluminescent element, display device, and lighting device 学校法人关西学院 2024-03-26 CN disclosed
EP-0345638-A1 4-[(Meth)acrylamidomethyl] pyrazoles and isoxazoles, process for their preparation and their use BASF Aktiengesellschaft (DE) 1989-12-13 EP disclosed
EP-0125701-B1 POLYCYCLIC AROMATIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1988-08-03 EP disclosed
US-4719236-A ANTITUMOR BURROUGHS WELLCOME CO. (US) 1988-01-12 US disclosed
EP-0125701-A2 Polycyclic aromatic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1984-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090128010-A1 Green Electroluminescent Compounds and Organic Electroluminescent Device Using the Same OCIAD1, OCIAD2, OPA1 ALDH1A1 11/4885HSD17B10 295/4885HPGD 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.